AsortinoBeta
Insulet Corporation logo

PODDInsulet Corporation

NASDAQStockHealthcareMedical Devices🇺🇸 United StatesISIN US45784P1012insulet.com
$147.482.06%
NASDAQ · at close Sep 4, 2026
Tokenized by
Dinari Inc. logoReality logo
2 issuersOn
Arbitrum One logoAvalanche C-Chain logoBase logoEthereum logo
6 chains

Chart data are delayed by 15 minutes.

1D2.06%
1M11.59%
3M+0.73%
1Y57.43%
3Y23.26%
5Y51.26%

Main metrics

$10.23B
27.62
$5.34
1.8M
1.08
$126.4052-week range$354.88

About PODD

Insulet Corporation is a medical device company focused on insulin delivery and diabetes management. Its flagship Omnipod platform includes wearable, tubeless insulin management systems designed to deliver continuous insulin without traditional pump tubing or multiple daily injections. The product line includes Omnipod 5, Omnipod DASH, and the Classic Omnipod, along with related pods, controllers, and diabetes management software that support day-to-day glucose control. Insulet also works with selected partners to adapt its Pod technology for the subcutaneous delivery of non-insulin therapies in other medical areas. Headquartered in Acton, Massachusetts, Insulet serves patients and healthcare providers across multiple international markets through direct sales and distribution channels.

Similar products

Abbott Laboratories logo
ABTNYSE
$108.330.42%
Abbott Laboratories
Ondo Finance logoBacked Finance logoReality logo
4 issuers · 15 chains
Bruker Corp. logo
BRKRNASDAQ
$58.501.53%
Bruker Corp.
Reality logo
1 issuer · 2 chains
Boston Scientific Corp. logo
BSXNYSE
$47.80+1.81%
Boston Scientific Corp.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 14 chains
DexCom Inc. logo
DXCMNASDAQ
$87.902.02%
DexCom Inc.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 13 chains